Viral Vector Services
Adenovirus Process Development & GMP Manufacturing
Utilize our extensive experience in Adenovirus GMP manufacturing solutions for adherent or suspension cell cultures, to ensure succesful scalability and GMP compliance.
Rely on us to deliver quality and efficiency within our bio-safety level 2 class facility.
Our unparalleled end-to-end service solution covers everything from sourcing GMP-grade materials and advanced manufacturing processes to aseptic filling, clinical labelling, GMP storage, and QP-approved release. Our qualified persons are dedicated to certifying products for clinical use before shipping with full GMP documentation and batch records while ensuring compliance and quality at every step.
Adenovirus production workflow
The adenovirus production workflow is carefully designed to ensure efficiency and quality at every stage.
Beginning with the selection of adherent or suspension cell cultures, we utilize scalable technologies to smoothly transition to GMP production.
Our end-to-end services streamline the process by including sourcing of GMP-grade raw materials and consumables from qualified providers.
Within our biosafety level 2 facility, the process ends with aseptic filling in a grade A/B production suite, then clinical labeling, GMP storage, and release approved by the Qualified Person (QP).
We prioritize regulatory compliance and adherence to industry standards to deliver reliable and high-quality adenovirus manufacturing services.
With you all the way…
together, making advanced biologics, and tomorrow’s life-transforming therapies.
We deliver unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substances and Drug Products, from pre-clinical to clinical development and commercial phases.
We support our customers wherever they are on their journey, from early-stage development to commercialization. We are passionate, precise, and always close, together, making advanced biologics and tomorrow’s life-transforming therapies.
Pre-Clinical
Phase I
Phase II
Phase III
Commercial